Effect of stapes demineralisation on the development of cochlear otosclerosis
CONCLUSIONS: Bone remodelling is most significant at the closest location to typical otosclerotic lesions with hydroxyapatite porosity and scale-like bone formation according to scanning electron microscopy. There is a relationship between the disturbance of calcium metabolism and the development of clinical symptoms of cochlear otosclerosis.PMID:38420840 | DOI:10.14639/0392-100X-N2389 (Source: Acta Otorhinolaryngologica Italica)
Source: Acta Otorhinolaryngologica Italica - February 29, 2024 Category: ENT & OMF Authors: Maciej Wiatr Robert Bartoszewicz Kazimierz Niemczyk Agnieszka Wiatr Source Type: research
Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review
Conclusion: Anosmia and ageusia are important symptoms of COVID-19 vaccination. These symptoms will resolve without any treatment in most cases, although some interventions may be needed in some patients.PMID:38411125 | DOI:10.1177/01455613241233098 (Source: Ear, Nose and Throat Journal)
Source: Ear, Nose and Throat Journal - February 27, 2024 Category: ENT & OMF Authors: Razman Arabzadeh Bahri Fatemeh Esmaeilpur Abianeh Maral Peisepar Reihaneh Hadi Fatemeh A Basti Saba Maleki Hanieh Radkhah Source Type: research
Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review
Conclusion: Anosmia and ageusia are important symptoms of COVID-19 vaccination. These symptoms will resolve without any treatment in most cases, although some interventions may be needed in some patients.PMID:38411125 | DOI:10.1177/01455613241233098 (Source: Ear, Nose and Throat Journal)
Source: Ear, Nose and Throat Journal - February 27, 2024 Category: ENT & OMF Authors: Razman Arabzadeh Bahri Fatemeh Esmaeilpur Abianeh Maral Peisepar Reihaneh Hadi Fatemeh A Basti Saba Maleki Hanieh Radkhah Source Type: research
Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review
Conclusion: Anosmia and ageusia are important symptoms of COVID-19 vaccination. These symptoms will resolve without any treatment in most cases, although some interventions may be needed in some patients.PMID:38411125 | DOI:10.1177/01455613241233098 (Source: Ear, Nose and Throat Journal)
Source: Ear, Nose and Throat Journal - February 27, 2024 Category: ENT & OMF Authors: Razman Arabzadeh Bahri Fatemeh Esmaeilpur Abianeh Maral Peisepar Reihaneh Hadi Fatemeh A Basti Saba Maleki Hanieh Radkhah Source Type: research
Withdrawal notice to: “Listening handicap in tinnitus patients by controlling extended high frequencies - Effort or fatigue?” [Auris Nasus Larynx 51 (2024) 198-205]
This article has been withdrawn: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). (Source: Auris, Nasus, Larynx)
Source: Auris, Nasus, Larynx - February 26, 2024 Category: ENT & OMF Authors: Eser Sendesen, Didem Turkyilmaz Source Type: research
Audiovestibular adverse events following COVID-19 vaccinations
CONCLUSIONS: This study is the first to demonstrate an increase in general practice presentations of vertigo following mRNA vaccines (RI = 1.40, P <.001), and tinnitus following both the Vaxzevria® adenovirus vector and mRNA vaccines (RI = 2.25, P <.001 and 1.53, P <.001 respectively). There was no increase in hearing loss following any COVID-19 vaccinations. Our study, however, was unable to account for the potential of concurrent COVID-19 infections, which literature has indicated to be associated with audiovestibular events. Healthcare providers and vaccinees should be alert to potential audiovestibular compla...
Source: Vaccine - February 23, 2024 Category: Allergy & Immunology Authors: Aishwarya N Shetty Hannah J Morgan Linny K Phuong John Mallard Diana Vlasenko Christopher Pearce Nigel W Crawford Jim P Buttery Hazel J Clothier Source Type: research
Audiovestibular adverse events following COVID-19 vaccinations
CONCLUSIONS: This study is the first to demonstrate an increase in general practice presentations of vertigo following mRNA vaccines (RI = 1.40, P <.001), and tinnitus following both the Vaxzevria® adenovirus vector and mRNA vaccines (RI = 2.25, P <.001 and 1.53, P <.001 respectively). There was no increase in hearing loss following any COVID-19 vaccinations. Our study, however, was unable to account for the potential of concurrent COVID-19 infections, which literature has indicated to be associated with audiovestibular events. Healthcare providers and vaccinees should be alert to potential audiovestibular compla...
Source: Vaccine - February 23, 2024 Category: Allergy & Immunology Authors: Aishwarya N Shetty Hannah J Morgan Linny K Phuong John Mallard Diana Vlasenko Christopher Pearce Nigel W Crawford Jim P Buttery Hazel J Clothier Source Type: research
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a systematic review and meta-analysis
ConclusionsOur systematic review and meta-analysis demonstrated a high overall tumor control rate, excellent facial nerve preservation, and low incidence of new-onset or worsened tinnitus and vertigo. However, several drawbacks associated with SRS should be noted, such as the presence of post-SRS hydrocephalus risk, mediocre long-term hearing preservation, and the lack of immediate tumor decompression. Nevertheless, the use of SRS may be beneficial in appropriately selected cases of Koos-IV VS. Moreover, further prospective studies directly comparing SRS with surgery are necessary to determine the optimal treatment for lar...
Source: Acta Neurochirurgica - February 23, 2024 Category: Neurosurgery Source Type: research
Emotional self-states and coping responses in patients with chronic tinnitus: a schema mode model approach
ConclusionsThe study provides initial clinical evidence for the relevance and applicability of schema-mode based formulation and treatment planning in patients with chronic tinnitus. (Source: Frontiers in Psychiatry)
Source: Frontiers in Psychiatry - February 21, 2024 Category: Psychiatry Source Type: research
